PDT Partners’s AbbVie ABBV Stock Holding History

PDT Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.86M	Buy	35,200 +29,600	+529%	+$6.37M	0.47%	66
2026 Q1	$1.22M	Hold	5,600	–	–	0.07%	309
2025 Q4	$1.28M	Sell	5,600 -2,800	-33%	-$638K	0.08%	317
2025 Q3	$1.94M	Hold	8,400	–	–	0.12%	258
2025 Q2	$1.56M	Buy	8,400 +6,400	+320%	+$1.19M	0.09%	343
2025 Q1	$419K	Buy	+2,000	New	+$389K	0.03%	557
2023 Q4	–	Sell	-10,000	Closed	-$1.49M	–	531
2023 Q3	$1.49M	Buy	+10,000	New	+$1.47M	0.19%	177
2022 Q4	–	Sell	-2,127	Closed	-$285K	–	602
2022 Q3	$285K	Buy	+2,127	New	+$305K	0.04%	609
2020 Q2	–	Sell	-417,300	Closed	-$31.8M	–	654
2020 Q1	$31.8M	Buy	417,300 +319,900	+328%	+$27.2M	2.52%	2
2019 Q4	$8.62M	Sell	97,400 -359,684	-79%	-$29.9M	0.53%	73
2019 Q3	$34.6M	Sell	457,084 -748,167	-62%	-$51.3M	2.06%	3
2019 Q2	$87.6M	Buy	+1,205,251	New	+$94.7M	5.18%	1
2015 Q4	–	Sell	-489,348	Closed	-$26.6M	–	393
2015 Q3	$26.6M	Buy	+489,348	New	+$31.9M	0.6%	23
2015 Q2	–	Sell	-365,843	Closed	-$21.4M	–	1312
2015 Q1	$21.4M	Buy	+365,843	New	+$22.1M	0.53%	26
2014 Q2	–	Sell	-368,679	Closed	-$18.9M	–	1382
2014 Q1	$18.9M	Buy	+368,679	New	+$18.6M	0.46%	40
2013 Q3	–	Sell	-207,479	Closed	-$8.58M	–	1466
2013 Q2	$8.58M	Buy	+207,479	New	+$9.07M	0.21%	114

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PDT Partners's ABBV Position: Q2 2026 in Review

PDT Partners increased its AbbVie (ABBV) stake by 529% in Q2 2026, buying an estimated $6.37M and bringing the position to 35,200 shares worth $8.86M. The position accounts for 0.47% of the portfolio, ranked #66.

PDT Partners first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $87.6M in Q2 2019. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PDT Partners held 35,200 shares of AbbVie worth $8.86M as of Q2 2026.
PDT Partners bought 29,600 AbbVie shares in Q2 2026, an estimated $6.37M.
AbbVie made up 0.47% of PDT Partners's portfolio in Q2 2026, its #66 holding.
PDT Partners first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
PDT Partners's AbbVie position peaked at $87.6M in Q2 2019.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.